New percutaneous approaches for chronic total occlusion of coronary arteries

Giora Weisz1, Jeffrey W Moses

  • 1Columbia University Medical Center, Center for Interventional Vascular Therapy, 161 Fort Washington Avenue, IP-5 Floor, New York, NY 10032, USA. gweisz@crf.org

Insights

Percutaneous coronary interventions for chronic total occlusions (CTOs) are advancing with new guidewires, techniques like retrograde approach, and devices. These innovations improve success rates for treating complex coronary artery disease.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology

Background:

  • Coronary artery chronic total occlusions (CTOs) represent a significant challenge in percutaneous coronary intervention.
  • Successful revascularization of CTOs is crucial for managing complex coronary artery disease and improving patient outcomes.

Purpose of the Study:

  • To review recent advancements in percutaneous coronary intervention for CTOs.
  • To highlight novel devices and techniques that enhance success rates and safety in CTO revascularization.

Main Methods:

  • Review of enhanced guidewires, retrograde approaches, and subintimal tracking and re-entry (STAR) techniques.
  • Discussion of novel devices including Safe-Cross radiofrequency and CROSSER catheter.
  • Exploration of emerging biologic approaches using proteolytic enzymes.

Main Results:

  • Enhanced guidewires, operator experience, and techniques like retrograde and STAR have made previously unapproachable CTOs treatable.
  • Novel devices such as Safe-Cross and CROSSER catheter aim to increase procedural success and safety.
  • Biologic approaches offer a new avenue for digesting CTO caps and facilitating passage.

Conclusions:

  • Interventional strategies for CTOs are rapidly evolving, improving outcomes for complex coronary artery disease.
  • Continued development of imaging modalities and energy-based catheters will further enhance CTO revascularization success rates.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...